We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Global Diagnostic Imaging Services Market to Reach USD 693.4 Billion by 2024

By MedImaging International staff writers
Posted on 24 Dec 2019
Print article
Image: Attractive Opportunities in the Diagnostic Imaging Services Market (Photo courtesy of MarketsandMarkets)
Image: Attractive Opportunities in the Diagnostic Imaging Services Market (Photo courtesy of MarketsandMarkets)
The global diagnostic imaging services market is projected to grow at a CAGR of 5.1% from USD 539.7 billion in 2019 to USD 693.4 billion by 2024, driven mainly by the rapidly rising geriatric population and subsequent increase in the prevalence of associated diseases, growing awareness about early disease detection and the widening scope of clinical applications. However, the high cost of diagnostic imaging systems and low reimbursement structure for outpatient imaging facilities are likely to restrain the market growth to some extent in the coming years.

These are the latest findings of MarketsandMarkets (Maharashtra, India), a market research and management consulting firm.

Based on modality, the X-ray segment accounted for the largest share of the global diagnostic imaging services market in 2018, led by the rising geriatric population, lower cost of X-rays as compared to other imaging modalities, favorable returns on investments, and technological advancements in X-ray imaging systems. On the basis of end-user, the hospitals segment held the largest share of the global diagnostic imaging services market in 2018, on the back of increasing number of diagnostic imaging procedures performed in hospitals, growing adoption of minimally invasive procedures in hospitals for improving the quality of patient care, and rising adoption of advanced imaging modalities to improve patient workflow efficiency in hospitals.

Geographically, North America held the largest share of the global diagnostic imaging service market in 2018, although Asia Pacific is estimated to record the highest CAGR during the forecast period, driven by improving healthcare infrastructure, rising investments in diagnostic imaging, improving reimbursement scenario, and growing insurance coverage in several countries in the region.

The market players have adopted several growth strategies, such as partnerships & agreements, joint ventures, and strategic acquisitions, to strengthen their service portfolios and maintain a competitive position in the market. RadNet (US) dominated the global diagnostic imaging service market in 2018. The company offers advanced imaging solutions, such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy, and other related procedures. RadNet focues on partnerships and acquisitions & joint ventures to enhance its presence in the market. For instance, in 2018, RadNet partnered with EmblemHealth (US) to expand its diagnostic imaging services in the New York metropolitan region. In the past three years, RadNet has acquired various players in the market and entered into a number of joint ventures to further strengthen its position in the market.

Related Links:
MarketsandMarkets

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Thyroid Shield
Standard Thyroid Shield
Ultrasound Needle Guide
Ultra-Pro II
New
1.5T MRI System
uMR 670

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.